Managing chronic pain in adults with haemophilia: Current status and call to action

Haemophilia

Volumn 21, Issue 1, 2015, Pages 41-51

  Humphries, T J ^a   Kessler, C M ^b  

^a BAYER CORPORATION   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Adult; Analgesics; Coping; Haemophilia; Paediatric; Pain

Indexed keywords

ACETYLSALICYLIC ACID; CODEINE; PARACETAMOL; TRAMADOL; NARCOTIC ANALGESIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANALGESIA; ARTICLE; CHRONIC PAIN; EMBASE; HEMOPHILIA; HUMAN; MEDICAL ASSESSMENT; MEDLINE; META ANALYSIS (TOPIC); PAIN ASSESSMENT; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PHASE 4 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STANDARDIZATION; TREATMENT OUTCOME; COMPLICATION; FEMALE; HEMOPHILIA A; MALE;

ADULT; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHRONIC PAIN; FEMALE; HEMOPHILIA A; HUMANS; MALE; PAIN MANAGEMENT;

EID: 84921449180     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12526     Document Type: Article

References (79)

1. Manco-Johnson MJ, Abshire TC, Shapiro AD et al. Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia. N Engl J Med 2007; 357: 535-44.
2. Classification of chronic pain. Descriptions of chronic pain syndromes and definitions of pain terms. Prepared by the International Association for the Study of Pain, Subcommittee on Taxonomy. Pain Suppl 1986; 3: S1-226.
3. den Uijl IE, Fischer K, Van Der Bom JG, Grobbee DE, Rosendaal FR, Plug I. Clinical outcome of moderate haemophilia compared with severe and mild haemophilia. Haemophilia 2009; 15: 83-90.
4. Holstein K, Klamroth R, Richards M et al. Pain management in patients with haemophilia: a European survey. Haemophilia 2012; 18: 743-52.
5. Riley RR, Witkop M, Hellman E, Akins S. Assessment and management of pain in haemophilia patients. Haemophilia 2011; 17: 839-45.
6. Witkop M, Lambing A, Divine G, Kachalsky E, Rushlow D, Dinnen J. A national study of pain in the bleeding disorders community: a description of haemophilia pain. Haemophilia 2012; 18: e115-19.
7. Forsyth AL, Gregory M, Nugent D et al. Haemophilia experiences, results and opportunities (HERO) study: survey methodology and population demographics. Haemophilia 2014; 20: 44-51.
8. Tsoukas C, Eyster ME, Shingo S et al. Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy. Blood 2006; 107: 1785-90.
9. Elander J, Robinson G, Mitchell K, Morris J. An assessment of the relative influence of pain coping, negative thoughts about pain, and pain acceptance on health-related quality of life among people with hemophilia. Pain 2009; 145: 169-75.
10. Ling M, Heysen JP, Duncan EM, Rodgers SE, Lloyd JV. High incidence of ankle arthropathy in mild and moderate haemophilia A. Thromb Haemost 2011; 105: 261-8.
11. Gringeri A, Mantovani LG, Scalone L, Mannucci PM. Cost of care and quality of life for patients with hemophilia complicated by inhibitors: the COCIS Study Group. Blood 2003; 102: 2358-63.
12. Humphries TJ, Kessler CM. The challenge of pain evaluation in haemophilia: can pain evaluation and quantification be improved by using pain instruments from other clinical situations? Haemophilia 2013; 19: 181-7.
13. Katz WA, Barkin RL. Dilemmas in chronic/persistent pain management. Am J Ther 2008; 15: 256-64.
14. Santavirta N, Bjorvell H, Solovieva S, Alaranta H, Hurskainen K, Konttinen YT. Coping strategies, pain, and disability in patients with hemophilia and related disorders. Arthritis Care Res 2001; 45: 48-55.
15. Zhang W, Doherty M, Leeb BF et al. EULAR evidence based recommendations for the management of hand osteoarthritis: report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2007; 66: 377-88.
16. Zhang W, Moskowitz RW, Nuki G et al. OARSI recommendations for the management of hip and knee osteoarthritis, part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008; 16: 137-62.
17. Minor MA, Sherry DD, Vallerand AH, Vasudevan S. Management of pain in osteoarthritis and rheumatoid arthritis. In: Simon LS, Lipman AG, Caudill-Slosberg M, Gill LH, Keefe FJ, Kerr KL et al., eds. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis and Juvenile Chronic Arthritis. 2nd ed., Chicago, IL: American Pain Society, 2002: 43-77.
18. American College of Rheumatology. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000; 43: 1905-15.
19. Luqmani R, Hennell S, Estrach C et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of rheumatoid arthritis (after the first 2 years). Rheumatology (Oxford) 2009; 48: 436-9.
20. National Institutes of Health. The management of sickle cell disease. Available at http://www.nhlbi.nih.gov/health/prof/blood/sickle/sc_mngt.pdf. Accessed January 31, 2014.
21. Hochberg MC, Altman RD, April KT et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken) 2012; 64: 465-74.
22. Jevsevar DS, Brown GA, Jones DL et al. The American Academy of Orthopaedic Surgeons evidence-based guideline on: treatment of osteoarthritis of the knee, 2nd edition. J Bone Joint Surg Am 2013; 95: 1885-6.
23. Zhang W, Nuki G, Moskowitz RW et al. OARSI recommendations for the management of hip and knee osteoarthritis, part III: changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthritis Cartilage 2010; 18: 476-99.
24. Avouac J, Gossec L, Dougados M. Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials. Osteoarthritis Cartilage 2007; 15: 957-65.
25. McAlindon TE, Bannuru RR, Sullivan MC et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage 2014; 22: 363-88.
26. American College of Rheumatology Subcommittee on Rheumatoid Arthritis. Guidelines for the management of rheumatoid arthritis: 2002 Update. Arthritis Rheum 2002; 46: 328-46.
27. Lee EY, Lee EB, Park BJ et al. Tramadol 37.5-mg/acetaminophen 325-mg combination tablets added to regular therapy for rheumatoid arthritis pain: a 1-week, randomized, double-blind, placebo-controlled trial. Clin Ther 2006; 28: 2052-60.
28. Mota LM, Cruz BA, Brenol CV et al. Guidelines for the drug treatment of rheumatoid arthritis. Rev Bras Reumatol 2013; 53: 158-83.
29. Rees DC, Olujohungbe AD, Parker NE et al. Guidelines for the management of the acute painful crisis in sickle cell disease. Br J Haematol 2003; 120: 744-52.
30. Dampier CD, Smith WR, Kim HY et al. Opioid patient controlled analgesia use during the initial experience with the IMPROVE PCA trial: a phase III analgesic trial for hospitalized sickle cell patients with painful episodes. Am J Hematol 2011; 86: E70-3.
31. van Beers EJ, van Tuijn CF, Nieuwkerk PT, Friederich PW, Vranken JH, Biemond BJ. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial. Am J Hematol 2007; 82: 955-60.
32. Watkins PB, Kaplowitz N, Slattery JT et al. Aminotransferase elevations in healthy adults receiving 4 grams of acetaminophen daily: a randomized controlled trial. JAMA 2006; 296: 87-93.
33. American Geriatrics Society Panel on Pharmacological Management of. Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. J Am Geriatr Soc 2009; 57: 1331-46.
34. Srivastava A, Brewer AK, Mauser-Bunschoten EP et al. Guidelines for the management of hemophilia. Haemophilia 2013; 19: e1-47.
35. National Hemophilia Foundation Medical and Scientific Advisory Council. MASAC document #162. Available at http://www.hemophilia.org/NHFWeb/MainPgs/MainNHF.aspx?menuid=57&contentid=176. Accessed April 9, 2014.
36. Motsko SP, Rascati KL, Busti AJ et al. Temporal relationship between use of NSAIDs, including selective COX-2 inhibitors, and cardiovascular risk. Drug Saf 2006; 29: 621-32.
37. Hippisley-Cox J, Coupland C. Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis. BMJ 2005; 330: 1366.
38. Bhamb B, Brown D, Hariharan J, Anderson J, Balousek S, Fleming MF. Survey of select practice behaviors by primary care physicians on the use of opioids for chronic pain. Curr Med Res Opin 2006; 22: 1859-65.
39. Results from the 2008 National Survey on Drug Use and Health: National Findings. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Available at http://www.samhsa.gov/data/NSDUH/2K8NSDUH/tabs/Sect1peTabs1to46.htm#Tab1.1B. Accessed August 27, 2012.
40. Manchikanti L, Manchukonda R, Damron KS, Brandon D, McManus CD, Cash K. Does adherence monitoring reduce controlled substance abuse in chronic pain patients? Pain Physician 2006; 9: 57-60.
41. Ballantyne JC. Opioid analgesia: perspectives on right use and utility. Pain Physician 2007; 10: 479-91.
42. Manchikanti L, Singh A. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Pain Physician 2008; 11: S63-88.
43. Bohn TM, Levy LB, Celin S, Starr TD, Passik SD. Screening for abuse risk in pain patients. Adv Psychosom Med 2011; 30: 113-24.
44. Chou R, Fanciullo GJ, Fine PG, Miaskowski C, Passik SD, Portenoy RK. Opioids for chronic noncancer pain: prediction and identification of aberrant drug-related behaviors: a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline. J Pain 2009; 10: 131-46.
45. Kahan M, Srivastava A, Wilson L, Gourlay D, Midmer D. Misuse of and dependence on opioids: study of chronic pain patients. Can Fam Physician 2006; 52: 1081-7.
46. Argoff CE, Kahan M, Sellers EM. Preventing and managing aberrant drug-related behavior in primary care: systematic review of outcomes evidence. J Opioid Manag 2014; 10: 119-34.
47. Noble M, Treadwell JR, Tregear SJ et al. Long-term opioid management for chronic noncancer pain. Cochrane Database Syst Rev 2010; 1: CD006605.
48. Ultram ER. (tramadol hydrochloride). Full Prescribing Information, Ortho-McNeil-Janssen Pharmaceuticals, Inc., Raritan, NJ, 2009.
49. Canadian Hemophilia Society. Available at http://www.hemophilia.ca/files/Pain-5th%20vital%20sign.pdf. Accessed June 25, 2014.
50. National Hemophilia Group Nursing Working Group. Nursing Working Group - Nurses' guide to bleeding disorders. Available at https://www.hemophilia.org/Researchers-Healthcare-Providers/NHF-Provider-Working-Groups/Nursing-Working-Group/Resources-for-Nurses/Nurses-Guide-to-Bleeding-Disorders. Accessed 2014, June 25.
51. World Health Organization. WHO's Pain Relief Ladder. Available at http://www.who.int/cancer/palliative/painladder/en/. Accessed August 26 2014.
52. Hasiba U, Scranton PE, Lewis JH, Spero JA. Efficacy and safety of ibuprofen for hemophilic arthropathy. Arch Intern Med 1980; 140: 1583-5.
53. Inwood MJ, Killackey B, Startup SJ. The use and safety of Ibuprofen in the hemophiliac. Blood 1983; 61: 709-11.
54. Steven MM, Small M, Pinkerton L, Madhok R, Sturrock RD, Forbes CD. Non-steroidal anti-inflammatory drugs in haemophilic arthritis. A clinical and laboratory study. Haemostasis 1985; 15: 204-9.
55. Thomas P, Hepburn B, Kim HC, Saidi P. Nonsteroidal anti-inflammatory drugs in the treatment of hemophilic arthropathy. Am J Hematol 1982; 12: 131-7.
56. Singh G, Fort JG, Goldstein JL et al. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study. Am J Med 2006; 119: 255-66.
57. Rattray B, Nugent DJ, Young G. Celecoxib in the treatment of haemophilic synovitis, target joints, and pain in adults and children with haemophilia. Haemophilia 2006; 12: 514-17.
58. Rattray B, Nugent DJ, Young G. Rofecoxib as adjunctive therapy for haemophilic arthropathy. Haemophilia 2005; 11: 240-4.
59. Kasper CK, Rapaport SI. Bleeding times and platelet aggregation after analgesics in hemophilia. Ann Intern Med 1972; 77: 189-93.
60. Trescot AM, Helm S, Hansen H et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11: S5-62.
61. Chou R, Fanciullo GJ, Fine PG et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain 2009; 10: 113-30.
62. Pokras SM, Petrilla AA, Weatherall J, Lee WC. The economics of inpatient on-demand treatment for haemophilia with high-responding inhibitors: a US retrospective data analysis. Haemophilia 2012; 18: 284-90.
63. LaBaw W. The use of hypnosis with hemophilia. Psychiatr Med 1992; 10: 89-98.
64. Wallny T, Brackmann HH, Semper H et al. Intra-articular hyaluronic acid in the treatment of haemophilic arthropathy of the knee. Clinical, radiological and sonographical assessment. Haemophilia 2000; 6: 566-70.
65. Garcia MK, Capusso A, Montans D, Massad E, Battistella LR. Variations of the articular mobility of elbows, knees and ankles in patients with severe haemophilia submitted to free active movimentation in a pool with warm water. Haemophilia 2009; 15: 386-9.
66. Wallny TA, Brackmann HH, Gunia G, Wilbertz P, Oldenburg J, Kraft CN. Successful pain treatment in arthropathic lower extremities by acupuncture in haemophilia patients. Haemophilia 2006; 12: 500-2.
67. Lambing A, Kohn-Converse B, Hanagavadi S, Varma V. Use of acupuncture in the management of chronic haemophilia pain. Haemophilia 2012; 18: 613-17.
68. Forsyth AL, Zourikian N, Valentino LA, Rivard GE. The effect of cooling on coagulation and haemostasis: should "Ice" be part of treatment of acute haemarthrosis in haemophilia? Haemophilia 2012; 18: 843-50.
69. Cuesta-Barriuso R, Gomez-Conesa A, Lopez-Pina JA. Physiotherapy treatment in patients with hemophilia and chronic ankle arthropathy: a systematic review. Rehabil Res Pract 2013; 2013: 305249.
70. Santavirta N, Solovieva S, Helkama O, Lehto S, Konttinen YT, Santavirta S. Musculoskeletal pain and functional ability in haemophilia A and B. Physiotherapy and rehabilitation in haemophilia patients. Rheumatol Int 2001; 21: 15-19.
71. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-63.
72. World Health Organization. WHO guidelines on the pharmacological treatment of persisting pain in children with medical illnesses. Geneva, Switzerland: WHO Press, 2012.
73. Tagliaferri A, Franchini M, Coppola A et al. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia 2008; 14: 945-51.
74. Valentino LA, Mamonov V, Hellmann A et al. A randomized comparison of two prophylaxis regimens and a paired comparison of on-demand and prophylaxis treatments in hemophilia A management. J Thromb Haemost 2012; 10: 359-67.
75. du Treil S, Rice J, Leissinger CA. Quantifying adherence to treatment and its relationship to quality of life in a well-characterized haemophilia population. Haemophilia 2007; 13: 493-501.
76. Hoots WK, Ebbesen LS, Konkle BA et al. Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors. Haemophilia 2008; 14: 466-75.
77. Klamroth R, Pollmann H, Hermans C et al. The relative burden of haemophilia A and the impact of target joint development on health-related quality of life: results from the ADVATE Post-Authorization Safety Surveillance (PASS) study. Haemophilia 2011; 17: 412-21.
78. Cicero TJ, Inciardi JA, Adams EH et al. Rates of abuse of tramadol remain unchanged with the introduction of new branded and generic products: results of an abuse monitoring system, 1994-2004. Pharmacoepidemiol Drug Saf 2005; 14: 851-9.
79. Viscusi ER, Pappagallo M. A review of opioids for in-hospital pain management. Hosp Pract (Minneap) 2012; 40: 149-59.